Search Results - "BULGER, T. F"
-
1
Administration of anaesthetic triggering agents to patients tested malignant hyperthermia normal and their relatives in New Zealand: An update
Published in Anaesthesia and intensive care (01-09-2017)“…Testing for malignant hyperthermia in New Zealand involves two tests-in vitro contracture testing of excised lateral quadriceps muscle and DNA analysis. In…”
Get full text
Journal Article -
2
Preparation of Datex-Ohmeda Aestiva® and Aisys® anaesthetic machines for use in malignant hyperthermia susceptible patients
Published in Anaesthesia and intensive care (01-05-2012)“…Preparation of anaesthesia machines for use by malignant hyperthermia susceptible patients requires purging the machines of halogenated anaesthetic agents. The…”
Get full text
Journal Article -
3
Safety of exposure of malignant hyperthermia non-susceptible patients and their relatives to anaesthetic triggering agents
Published in Anaesthesia and intensive care (01-09-2011)“…As the reliability of malignant hyperthermia normal in vitro contracture test results has been questioned, this study set out to determine the reliability of…”
Get full text
Journal Article -
4
Evidence of Malignant Hyperthermia in Patients Administered Triggering Agents before Malignant Hyperthermia Susceptibility Identified: Missed Opportunities Prior to Diagnosis
Published in Anaesthesia and intensive care (01-11-2017)“…Malignant hyperthermia (MH) is a hypermetabolic disorder of skeletal muscle triggered almost exclusively by potent inhalational agents and suxamethonium. Signs…”
Get full text
Journal Article -
5
Evidence of malignant hyperthermia in patients administered triggering agents before malignant hyperthermia susceptibilityidentified: Missed opportunities prior to diagnosis
Published in Anaesthesia and intensive care (01-11-2017)“…Malignant hyperthermia (MH) is a hypermetabolic disorder of skeletal muscle triggered almost exclusively by potent inhalational agents and suxamethonium. Signs…”
Get full text
Journal Article